I'm looking to add, if it breaks 8.3 cleanly. I think shorts don't want to lose this stock till next year.
Nothing in the presentation, but one never knows about post presentation discussions.
I'm thinking short covering. They waited till the presentation was over to see if the covering coast was clear. But this assumes cover then bring it back down, and it actually is trading quite well (strong).
I did not know whether to guess $8.50 or $6.50. Nice move yesterday, following though today it looks. Short covering, or perhaps some post presentation share buying?
Nothing new disclosed at the conference. The same problem still plagues this company - they have a very expensive marketing launch coming up in 2014 for OMS302, so they either need to do another capital raise or partner something. Nobody will believe the value of their pipeline until they partner something - why haven't they partnered OMS302 in Europe, yet. A couple of their pipeline drugs are ripe for partnering - they keep bragging about the value of their drug discovery platform - they've "unlocked" 52 orphan GPCR's - how about selling the rights to one of them and maybe people will believe you're just not #$%$ shareholder money away!
did sell about 1/2 of my shares I bought at 3.80 in the low 12s. LOL -- made more on that 1/2 than you have made in your investment career. never going to get back to your $5 short target
I'm telling you, as I said yesterday, the comments about a partnership are important and would not have been mentioned if there were not something up coming. Patience, 2014 looks to be a big year for OMER
Wish we had some volumn to support the rise, although it appears to be picking up.